[] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q (CEO) CERTIFICATION I, Shanchun Huang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Future FinTech Group Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a mat]
[Unless otherwise defined in this announcement, capitalized terms used herein shall have the same meanings as those defined in the Hong Kong prospectus dated June 2, 2020 issued by NetEase, Inc. NetEase, Inc. (Incorporated in the Cayman Islands with limited liability) (Stock Code: 9999) STABILIZING A]
[] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q (CEO) CERTIFICATION I, Shanchun Huang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Future FinTech Group Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a mat]
[Unless otherwise defined in this announcement, capitalized terms used herein shall have the same meanings as those defined in the Hong Kong prospectus dated June 2, 2020 issued by NetEase, Inc. NetEase, Inc. (Incorporated in the Cayman Islands with limited liability) (Stock Code: 9999) STABILIZING A]
[Himax Technologies, Inc. Pre-announces Preliminary Unaudited Second Quarter 2020 Financial Results Revenues, Gross Margin and EPS all Exceed Guidance th th TAINAN, Taiwan, July 06, 2020 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless]
[Himax Technologies, Inc. Pre-announces Preliminary Unaudited Second Quarter 2020 Financial Results Revenues, Gross Margin and EPS all Exceed Guidance th th TAINAN, Taiwan, July 06, 2020 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless]
[Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval from Brazilian Regulator for Phase III Trial Beijing-July 6, 2020 — Sinovac Biotech Ltd. ( “Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced an update to its pre]
